Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

SAR described for small-molecule ETA antagonists from ImmunoPharmaceutics

July 30, 1997

Efficacy reported for FR-167653 in animal model of septic shock

July 30, 1997

Human SMC migration factor and modulators thereof described by SKB and HGS

July 30, 1997

Merck KGaA discloses novel ET antagonists

July 29, 1997

Calcium supplementation does not prevent life-threatening disorder of pregnancy

July 28, 1997

NPY antagonists from Thomae

July 25, 1997

Phosphodiesterase inhibitors from Schering-Plough

July 24, 1997

NPY antagonists developed at Thomae

July 24, 1997

New alinidine analogues described

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...